MacKenzie G M, Rose S, Bland-Ward P A, Moore P K, Jenner P, Marsden C D
Neurodegenerative Diseases Research Centre, King's College, London, UK.
Neuroreport. 1994 Oct 3;5(15):1993-6. doi: 10.1097/00001756-199410000-00039.
7-Nitro indazole (7-NI) inhibits rat striatal, cerebellar, hippocampal, cerebral cortex and olfactory bulb nitric oxide synthase (NOS) in vitro with IC50 values of 0.68 +/- 0.01 microM, 0.64 +/- 0.03 microM, 1.53 +/- 0.05 microM, 0.93 +/- 0.04 microM and 1.05 +/- 0.02 microM respectively (n = 6). Intraperitoneal (i.p.) or oral administration of 7-NI (30 mg kg-1) to rats inhibited NOS enzyme activity measured ex vivo in all five brain regions (n = 5-6). NOS inhibition (maximal effect, 0.5 h post-injection) was transient with complete recovery at either 4 h (oral administration) or 24 h (i.p. administration). Repeated i.p. injection of 7-NI (30 mg kg-1, every 4 h for 20 h) inhibited NOS enzyme activity at 24 h by 51-61% in all brain regions. The relatively transient NOS inhibitory effect of 7-NI following parenteral administration should be taken into account when using this drug to evaluate the central effects of nitric oxide.
7-硝基吲唑(7-NI)在体外可抑制大鼠纹状体、小脑、海马、大脑皮层和嗅球中的一氧化氮合酶(NOS),其半数抑制浓度(IC50)值分别为0.68±0.01微摩尔/升、0.64±0.03微摩尔/升、1.53±0.05微摩尔/升、0.93±0.04微摩尔/升和1.05±0.02微摩尔/升(n = 6)。给大鼠腹腔注射(i.p.)或口服7-NI(30毫克/千克)可抑制在所有五个脑区离体测量的NOS酶活性(n = 5 - 6)。NOS抑制作用(最大效应,注射后0.5小时)是短暂的,在4小时(口服给药)或24小时(腹腔注射给药)时可完全恢复。重复腹腔注射7-NI(30毫克/千克,每4小时一次,共20小时)在24小时时可使所有脑区的NOS酶活性抑制51% - 61%。在使用该药物评估一氧化氮的中枢作用时,应考虑7-NI经肠胃外给药后相对短暂的NOS抑制作用。